# ClinicalTrials.gov record NCT03471728

> PeptideScanner retained ClinicalTrials.gov record NCT03471728 at 2026-07-30T18:39:33.779Z. Its registry update date was 2024-10-18, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct03471728-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-10-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03471728-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03471728-linaclotide-v1.json
- Content SHA-256: `93e7b389e2f632d1fc06e960045c878a8d2f070daa91e256882d20b7b67d81b1`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03471728 ([`ctg-observation-nct03471728-2024-10-18-972598ce2ea3`](#source-ctg-observation-nct03471728-2024-10-18-972598ce2ea3))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03471728 at 2026-07-30T18:39:33.779Z. Its registry update date was 2024-10-18, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03471728-2024-10-18-972598ce2ea3`](#source-ctg-observation-nct03471728-2024-10-18-972598ce2ea3))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03471728 at 2026-07-30T18:39:33.779Z. Its registry update date was 2024-10-18, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03471728-2024-10-18-972598ce2ea3`](#source-ctg-observation-nct03471728-2024-10-18-972598ce2ea3))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03471728-2024-10-18-972598ce2ea3`](#source-ctg-observation-nct03471728-2024-10-18-972598ce2ea3))

## Sources

<a id="source-ctg-observation-nct03471728-2024-10-18-972598ce2ea3"></a>
- **ClinicalTrials.gov record NCT03471728 · retained source version 2024-10-18:972598ce2ea3019692aeac8eab2d77443fe2c07b400759d221ff0ca477f42043** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03471728) (`ctg-observation-nct03471728-2024-10-18-972598ce2ea3`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03471728." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03471728-linaclotide-v1.json SHA-256: 93e7b389e2f632d1fc06e960045c878a8d2f070daa91e256882d20b7b67d81b1.